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Background Assent is used to take children’s wishes into account when they are invited into
clinical trials, but the concept has attracted considerable criticism. We investigated children’s
accounts of decision-making with the aim of informing practice in supporting children when invited
to join a clinical trial.
Methods We audio-recorded qualitative, semi-structured interviews with 22 children aged
8–16 years about being invited to take part in a clinical trial. Most children were interviewed with
their parents. Analysis of the transcribed interviews examined the content of participants’ accounts
thematically, whilst also drawing on principles of discourse analysis, which examines how individuals
use talk to achieve certain effects or social practices.
Results It was not possible to separate children’s knowledge of the clinical trial, or their decision-
making processes from that of their parents, with parents taking a substantial mediating role in
producing their children’s decisions. Decision-making gradually unfolded across time and events
and was interwoven within the family context, rather than happening in one moment or in the
clinical setting. Whilst children valued their parents’ role, a case study of child–parent disagreement
indicated how children can struggle to be heard.
Conclusions Decisions happen within a process of family dynamics, in contrast to ideas of assent
that isolate it from this context. Parents have a substantial role in children’s decisions, and thus how
families come to provide consent. Reflecting this we argue that assent practices need to focus on
supporting parents to support their children in learning and deliberating about trials. However, this
needs to be accompanied by practitioners being alert to the possibility of divergence in child and
parent views and enabling children’s perspectives to be heard.
Introduction
Whilst competent children can consent to clinical treatment,
children entering clinical trials of medicines within the UK and
many other countries are not legally permitted to give
informed consent for themselves (Medicines for Human Use
(Clinical Trials) Regulations 2004). This gives rise to the
problem of how to include children in the research consent
process. It is vital for children take part in clinical trials to
ensure that advances in their treatments are evidence-based;
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data on children’s treatments cannot simply be extrapolated
from clinical trials in adults (Gill 2002; Salazar 2003), as
children’s illnesses can be distinct to those of adults and
children can respond to treatments in different ways compared
to adults. Current practice is to seek proxy consent from an
adult, usually the parent, and include the child’s wishes by
seeking their assent (Joffe et al. 2006; Alderson 2012). Assent is
a problematic concept, as it must be applicable to a large range
of children, from very young children who may struggle to
articulate a view, to teenagers judged almost competent enough
to give consent (Rossi et al. 2003).
Questions about how assent can be managed, achieved in
practice and how much of a role a child can take in making the
decision about whether to enter a trial are the topic of much
debate (Alderson 2007; Baines 2011). It is not clear that assent
gives the child any true legal power to dissent if parents want
their child to enter a trial (Baines 2011; Blake et al. 2011).
There are also suggestions that assent does not do justice to the
extent to which children are able to participate in decision-
making (Alderson et al. 2006b; Snethen et al. 2006; Miller et al.
2008) and that it neglects the social context in which decisions
are made. A child’s engagement in decision-making will
depend on the relationships, processes and materials available
to support them (Brody et al. 2005; Pinxten et al. 2008).
Much biomedical research on assent focuses on competence
as a characteristic of the child (Tait et al. 2003; Hein et al. 2014)
set apart from their context, investigating how far a child is
able to achieve the building blocks of an agreement to take part
in research. These components are taken to be, an under-
standing of the treatments, ability to deliberate and choose, to
communicate an active preference and to understand their
right to leave (Rossi et al. 2003; Miller et al. 2004). Some of this
work aims to identify age-related competencies (Rossi et al.
2003; Swartling et al. 2011) and inform decisions about the age
at which children can meaningfully agree to participate in
research.
In contrast, social science researchers have tended to view
competence as context dependent, influenced by a child’s
experience of illness and relationships with parents over the
course of decision-making (Alderson et al. 2006b). Linked to
this emphasis on the context and relationships, decision-
making about children’s participation in research has been
conceptualized as a ‘family consent’ process (Miller et al. 2004;
Gibson et al. 2011), which draws attention to the role of family
structures and hierarchies in decision-making (Heritage &
Maynard 2006). Traditionally, parents have responsibility for
making decisions on behalf of children and might therefore be
assumed to approach decision-making from a position of
authority. However, parents may feel vulnerable as they
balance their authority with expectations to involve their child
in decision-making (Silverman 1987; Arribas-Ayllon et al.
2011; Nuffield Council on Bioethics 2015). Fears of making the
‘wrong’ decision and the regret this would bring, and about
children’s susceptibility to potentially harmful treatments
(Read et al. 2009; Shilling & Young 2009; Salmon et al.
2012), may exacerbate parents’ sense of vulnerability.
Whilst much has been written about assent as a concept,
little empirical work has involved children to inform these
ideas and whether they resemble children’s decision-making in
practice. Empirical work is needed to inform conceptualiza-
tions of assent, identify how best to support children in making
decisions about research participation and inform the design of
resources to support their decisions. Much of the empirical
work that is available sidesteps the contextual complexities by
using hypothetical scenarios, or involving children and families
who have no experience of trials (Corrigan 2003; Miller et al.
2004; Hunfeld & Passchier 2012) and evidence is needed about
decision-making in real world situations. Inductive qualitative
methods are helpful in exploring taken for granted assump-
tions and processes that may be otherwise be overlooked,
particularly in areas that have previously been little investigated
(Murphy et al. 1998). We adopted such an approach,
interviewing children who had been invited to join a trial
and exploring how they and their parents described this
invitation and the decision-making process. We considered
how well assent, as it is conceptualized in both the biomedical
and social science literature, is compatible with how families
make decisions about children’s entry into clinical trials. Our
overall aim was to inform practice in supporting children’s
decision-making about research.
Methods
Sampling and recruitment of clinical trials and families
We interviewed children as part of a larger qualitative study
(Shilling et al. 2011b; Shilling et al. 2011a), called RECRUIT,
investigating recruitment to four publically funded placebo-
controlled, randomized clinical trials of medicines for children.
Recruitment to these trials involved one or more face-to-face
discussions between families and clinical trial clinicians. Whilst
the children’s interviews are the focus of this paper, the
RECRUIT study also investigated parent-practitioner commu-
nication during recruitment. The wider dataset comprised
audio-recordings of discussions between families and family-
clinicians about the trials, as well as interviews with parents
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and clinicians. The methods of this larger study are described
in detail elsewhere (Shilling et al. 2011b).
From a pool of 14 potentially eligible trials, we purposively
sampled four trials to encompass variation in the severity of
illness and circumstances under which families were invited to
join the trials. Clinical trial clinicians at 11 sites invited
families to participate in RECRUIT, usually in person or by
telephone. RECRUIT interviewers subsequently telephoned
interested families to give more information about the study
and arrange the interviews. Sampling across the four trials
comprised a mix of consecutive and purposive sampling.
Consecutive sampling aimed to avoid clinicians ‘cherry
picking’ families, whilst purposive sampling aimed to
encompass diversity in socio-demographic characteristics
and whether children participated in the trials, declined,
withdrew or were ineligible. Of the 95 families invited for an
audio-recording of the clinician–parent discussion and/or
qualitative interview, members of 60 (63%) families were
interviewed; the remainder were either not approached for
interview following the audio-recorded discussion (n=5) or
did not consent to interview. Within the three trials that are
the focus of this paper (the fourth trial focussed solely on
neonates and is not discussed further) we interviewed
members of 48 families. Of these, 22 families were from the
most materially deprived fifth of the UK population (based on
the Index of Multiple Deprivation) and three families were
from a minority ethnic group.
As the topic of clinical trial recruitment was rather abstract
and likely to be difficult for young children, we did not
interview those aged less than 8 years. Out of the remaining 34
families with children aged eight or over, children from 12
families were not interviewed, either because parents advised
that an interview would not be suitable (the children had
severe neurodevelopmental problems), or because the child
declined. Of the 22 interviewed children, 11 were female; eight
were aged 8–10 years, eight were 11–13 years and six were
14–16 years. Eighteen interviewed children lived in North West
England or the West Midlands, and four in Northern Ireland.
Thirteen children were interviewed about a rheumatology trial,
seven about a respiratory trial and two about a
neurodevelopmental trial. Most interviews took place in the
family home and lasted between 15 and 30minutes. Eight
children asked to be interviewed jointly with their parents, two
were interviewed alone and twelve parents (11 mothers, 1
father) were present for at least some of the child’s interview
and contributed to some degree. One child’s interview did not
contain any content relevant to the trial and was therefore
excluded from the analysis.
Ethics
Our access to children was usually negotiated via their parents,
and reflecting this we obtained informed consent for children’s
participation from their parents. After discussing the study
with children, if researchers thought children understood the
study they sought their informed consent (in addition to
parental consent) and asked children to sign their own consent
forms. Otherwise researchers sought children’s agreement to
participate and asked them to sign an assent form. A UK
National Health Service research ethics committee gave
approval for RECRUIT (Northwest 5 Research Ethics
Committee: 07/MRE08/6). All data have been anonymized,
and specific details of the trials, as well as exact ages of the
children omitted to minimize risk of participants being
identified.
The trials and recruit interview schedule and procedures
Of the three trials, one investigated treatment for a symptom of
a chronic respiratory illness, one investigated treatment to
combat a major side effect of treatment for a rheumatological
illness and one investigated a treatment to manage ongoing
problems associated with a neurodevelopmental condition.
During the face-to-face discussions with families, clinicians
outlined the trial aims, main procedures, what participating
would entail, treatments being investigated and any accompa-
nying risks. Information leaflets containing similar details
about each of the trials were provided to both parents and
children; the latter were available in several age-appropriate
versions. As we describe elsewhere (Shilling et al. 2011b),
children and parents were often largely silent in the discussions
with clinicians, although they usually had several weeks
afterwards to make a decision about the trial. During this
time families could consult the leaflets, as well as contact
clinicians with queries, although we do not know how
frequently families initiated such contact.
VS and ES conducted topic-guided semi-structured
interviews with children between March 2008 and January
2010, in the families’ homes. They used several techniques to
help children, particularly those in younger age groups to feel
comfortable. For example, at the start of the interviews the
researchers laid out cards with familiar pictures (such as a
horse or boat), on one side and a question on the other side.
Children selected a card to begin a topic. After each topic had
been discussed they placed a sticker on the card to mark it as
complete before selecting a new card. This aimed to help
children feel comfortable by bringing a game-like quality to the
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interaction. If parents were present, interviewers were careful
to direct their questions towards children to maintain a sense
that the child was the ‘owner’ of the interview. We developed
different versions of the topic guides for younger and older
children. These explored the background of the child’s illness,
their views of the trial, how well their needs were met, how
they had made the decision about the trial and who influenced
it, the written information provided and their views on clinical
research. Example questions included: ‘If I ask you to think
about [trial] now, is there anything that comes to mind? Did
you have any worries about taking part in the [trial]? Were you
able to ask questions?’ Researchers aimed to cover the same
topics in each interview, whilst adapting questions for each
participant and prompting as appropriate so that interviews
were conversational. We audio-recorded all interviews, and
transcribed them verbatim, with some idealization such as
adding punctuation.
Data analysis
LM led the analysis with support from BY and VS. Analysis
explored the content of participants’ accounts inductively and
thematically, whilst also drawing on the principles of discourse
analysis (Potter & Wetherall 1987; Silverman 1987). Discourse
analysis focuses on the ways that participants talk, treating
interviews not as presentations of participants’ perspectives,
but as acts to achieve particular effects, such as influencing or
eliciting certain responses from others (Austin 1962). There-
fore, we considered participants’ accounts in the context of
imperatives for them to speak in socially and morally expected
ways. For patients and parents describing their decision-
making there is pressure to present themselves as responsible
and active deciders (Silverman 1987; Arribas-Ayllon et al.
2008). We attended to participants’ work of creating this effect,
particularly in parts of the interviews where children and
parents were speaking to each other and explaining themselves
interactionally. Procedurally the analysis was iterative, with
transcripts being read several times, first to identify material
relevant to the research questions, before analysing this
material in detail to consider how participants positioned
themselves in relation to the trial information and the different
ways in which participants talked about the decision-making,
and the discursive strategies children and parents used to
negotiate their positions. LM and BY periodically discussed the
developing analysis and all authors, particularly VS, contrib-
uted to this process by commenting on reports of the analysis
containing extensive data extracts.
We addressed quality by considering ‘negative’ cases, as
illustrated in the case study that we describe (Murphy et al.
1998), and by providing contextual detail to help readers make
sense of the findings and assess their transferability. More
broadly, we considered the analysis in terms of its catalytic
validity, that is, its potential to inform practice (Kincheloe &
Mclaren 2000). Excerpts quoted (Table 1) are representative of
categories found in the analysis of data as a whole; all names
are pseudonyms and children’s age ranges are indicated. Where
Table 1. The work of understanding trials and parents’ role in producing
assent
Extract 1: 14–16 years
Ellie: the leaflets have to have them, although I don’t read them, but […] my
mum does and […] and she goes through it but kids don’t really.
Well I’m saying I don’t read… I don’t like reading them.
Extract 2: 8–10 years
Researcher: Do you prefer to chat to the doctor or chat to mum?
Jack: Just watch TV or play on my DS or look at magazines.
Extract 3: 8–10 years
Jordan: Yea, I talk to my mummy and I don’t know what you said,
I can’t remember.
Mother: You had a leaflet, didn’t you, and you read that and I just
told you a bit about it, and then
Jordan: That was it.
Mother: Asked you what you thought
Extract 4: 14–16 years
Lisa: Yeah, the whole idea that other people had been doing it and that it’s,
it’s not a new drug because mum was saying I would have […] I probably
wouldn’t have been as open to it if I hadn’t been on a similar medicine
before.
Extract 5: 11–13 years
Mark: I didn’t want to take part in the trial at first, in case there were
injections. Then mother explained there wouldn’t be. So I was happy to
do the trial.
Extract 6: 8–10 years
Researcher: Can you remember who it was who first mentioned the trial?
Emily: Um, not it wasn’t, was it, mum?
Mother: The very first person that mentioned the study was
[consultant name]
Extract 7: 8–10 years
Researcher: Did you feel like you were free to leave the trial?
Gemma: I don’t know. Can you help me mum?
Mother: I don’t know how you felt babe! Did you ever think ‘Oh, I don’t
want to do this no more’? With your fizzy medicine and you’re..?
Gemma: Not really, no
Mother: Well there you go then, babe.
Extract 8† : 14–16 years
Ellie: I like my mum being in on it so that if there’s anything I’m concerned
about I can say to my mum
Extract 9† : 11–13 years
Oliver: If I said ‘yes’ but my mum and dad said didn’t approve well. I just
probably would say ‘can we talk about it?’ because if they don’t approve
I won’t be, feel confident about it will I?
† These extracts are reproduced from Shilling et al. (2011b) Processes in
recruitment to randomized controlled trials of medicines for children
(RECRUIT): a qualitative study. Health Technology Assessment, 15, 1–116.
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quotes have been shortened for brevity or to remove
potentially identifying detail, omitted text is marked with
‘[…]’.
Results
Overview
In the following sections we describe how children’s
understanding of the trials arose from collaborative work
within families. We particularly focus on one child whose
parents overtly persuaded her to enter a trial, yet our findings
also show other parents being similarly, if more subtly,
influential in shaping their child’s engagement with the trial.
The findings show that children not only evoked such
responses from parents, but also that children relied upon
and mostly valued this work by parents. Quoted data extracts
are shown in Tables 1 and 2.
The work of understanding trials
From their accounts of being invited to join the trial, it was
apparent that some children were content to delegate much of
the work of finding out about the trial to their parents. As
extracts 1 and 2 illustrate (Table 1), these children implied that
they wanted little engagement with the written or verbal
information about the trials, instead relying on their parents to
do this work. This is despite children having been provided
with adapted versions of the trial information leaflets, and
clinicians’ having tried to direct explanations and questions to
children during the family-clinician discussions about the
trials.
Other children had engaged with the trial information to
some degree, but it was still common for them to describe how
their knowledge or opinions of the trials had derived from
their parents’ explanations. Extract 3 (Table 1) shows how
Jordan, a younger child, relied on his mother to provide the
bulk of the description for the interviewer. As the mother’s talk
indicates, she not only mediated information about the trial,
but also the process of eliciting her child’s views. Similarly, in
extract 4 (Table 1), whilst Lisa offered a sophisticated view
about making the decision to join a trial, her phrase ‘because
mum was saying’, indicated that parts of Lisa’s description had
come from her mother. Moreover, in using this phrase, Lisa
could be seen as invoking adult views in order to add
legitimacy to her account. Several children went further and
explicitly described how their parents went through a process
of explaining the trial to them. In extract 5 (Table 1), Mark
spoke of having initially misunderstood the trial treatment. He
then referred to his mother’s explanation of the treatment and
how this had helped him to move forward in his understand-
ing of the trial and give assent.
The work of understanding the trials could therefore be seen
as located not within the child themselves, but as a relational
process, in which children and parents collaborated to varying
degrees, but with parents taking a substantial mediating role
(Corrigan 2003).
Parents’ role in producing assent
The kind of collaboration between parent and child as seen
above was not only reported by children; it could be seen in
how participants talked within the interviews. As with Lisa
above, children’s reports of their parent’s perspective could
help them achieve a legitimacy that they might not have had
alone. Children also frequently requested help from parents as
in extract 3. The contribution of parents varied in its impact on
the interview. In extract 6 (Table 1), for example, Emily
seemed to struggle with a somewhat technical question, which
her mother stepped in to answer after Emily had asked for
her help. However, parents’ contributions could go beyond
simply helping. As extract 7 (Table 1) indicates, parents could
subtly yet significantly transform the discussion, in this case by
reworking the interviewer’s question so that Gemma ended up
answering a much ‘weaker’ question, which lacked the enquiry
into voluntarism of the original question.
Therefore, parental input, although collaborative, did not
just involve neutrally helping their children with interview
questions. Parents’ interjections inevitably reflect their own
views and priorities, and through this type of collaborative
Table 2. A case study: entering a trial then leaving it
Extract 10: 11–13, female
Katy: I felt a bit under pressure, yea! Umm. I’m not sure because I don’t think
it was my decision, I think it was Mum’s and Dad’s really! […] But, Um, I just
decided to do it in the end, to kind of get them to be quiet!
Extract 11: Mother: We did persuade Katy, I suppose when the study started,
she wasn’t normal Katy, you know. She would, I suppose, agree to lots of
things maybe. And then as it got towards early summer, you know, she’s very
much getting her own voice back. And of course, she was wheedling away in,
looking every way possible to try and stop taking different medicines […] it’s
not like you’ve got an eight year old and ‘you have to take that!’. She knew
it was optional because she’d been told that in the first place. Well if she
hadn’t been told it was optional we might have managed to keep her on!
Extract 12: Mother: Honestly, she can be quite strong willed when she’s
getting better and she’s been through such a lot […] as she’s going to get
better, Katy will say no to lots of things.
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work, parents directed their children’s understanding of the
trials. As extracts 8 and 9 (Table 1) illustrate, children spoke of
relying upon and valuing their parents’ collaboration.
These collaborative styles of interaction were a recurrent
pattern throughout the data and taken together suggest that it
is not realistic to treat the child’s preferences and opinions as
separate to those of their parents. It is not only that parents
explicitly influenced children’s views, with several children
reporting having changed their minds over the course of the
decision-making process; parents could be seen as working in
nuanced ways to ‘produce’ assent by directing their child’s
engagement with the trial, comprehension of procedures and
ability to show a preference. The extent of the parental role
adds to doubts about assent and whether it is a meaningful
concept (Baines 2011).
A case study: entering a trial and then leaving it
The first part of this paper has considered some specific
elements of how children’s preferences are developed and
managed within the family. We have looked at how the child’s
understanding is based on the explanations of parents, and
how parents can also subtly reframe issues to mediate their
child’s account of the trial. This strong role of parents can
erode the notion that assent is the child’s own view, as parents
have considerable, and often subtle persuasive power, in how
they develop their child’s knowledge and engagement with the
trial.
In the final section we consider the case of one family in
more detail, to give a sense of the entire decision-making
process, and how it unfolded over several months. This also
aims to illustrate how we worked through the data analysis, to
incorporate ‘negative’, or less simple, cases (Murphy et al.
1998). We particularly describe how this family’s account of
decision making was embedded in day-to-day family life
(Arribas-Ayllon et al. 2011), and intertwined with coming to
terms with a diagnosis of a serious illness.
Doing some good: entering the trial
Shortly after Katy’s diagnosis she was invited to enter a clinical
trial for a medicine that offered the potential to minimize a
long term side effect of one of the standard medications for her
condition. She initially entered the trial, with the key argument
from her parents, that the trial treatments would do no harm,
and might do some good in offering a potentially protective
treatment and a level of monitoring that Katy was not receiving
as part of her standard care. Whilst Katy initially entered the
trial based on her parents’ views, extract 10 (Table 2) shows
there was already some disagreement within the family at the
point of trial entry. This was described with ambivalence about
who made the decision. Although Katy had relinquished her
own claim to voluntarism, by describing it as her parents’
decision, she explained the process in negative terms, referring
to ‘pressure’, and wanting her parents ‘to be quiet’.
Too many treatments: experience of the trial
Whilst Katy’s mother described her daughter’s position as
‘Poor Katy just wanted to be left alone, didn’t you?’ in extract 11
(Table 2) several different positions were introduced about the
significance of Katy’s own view. The parents framed them-
selves as using ‘persuasion’, whilst in contrast describing Katy
as ‘wheedling’, and looking for ways to minimize the number
of treatments in her regimen. Her mother indicated several
circumstances that strengthened Katy’s position to make a
decision for herself. These included Katy’s age, and the
implications that follow for voluntarism, Katy ‘getting her
own voice back’ as she recovered from the illness, and being
empowered by the trial’s assent process. Katy’s mother
indicated she would have liked to keep her daughter in the
trial despite Katy’s desire to leave. She also minimized Katy’s
reasons for wanting to leave the trial and framed the assent
process as a rather negative influence in giving Katy the tools to
leave.
‘Strong will’ and ‘persuasion’: the management of a
decision to leave
In her final summary, Katy’s mother described the decision to
withdraw from the trial as one that Katy largely made. Katy’s
withdrawal was the conclusion of disagreements that took
place over a series of months and were managed within the
family. Katy gained a form of authority within this family
process through her ‘strong will’, from having ‘been through
such a lot’, and also from her reluctance to enter the trial from
the beginning and maintaining this stance over several months.
Katy being of an age that meant she could offer some
deliberation and must have some of her own say added to her
authority. This package of circumstances gave Katy a stronger
relationship to the deliberations required of an informed
consent model. However, her dissent was not attained in any
clear cut way. Indeed, she might never have achieved this final
triumph of her views without the assent process that informed
her of her right to leave, and she still had a lengthy struggle,
over time and through the dynamics of the family, to finally
achieve it.
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Discussion
We explored how decisions about consent for children’s
clinical trial enrolment are managed in the context where these
decisions are made. We found that children’s views owe much
to the explanations and subtle scaffolding work of parents.
Children were strongly influenced by their parents and seemed
to want this influence. Even when a child held strong views
about a particular treatment, these often changed readily in
discussion with a parent.
We looked in more detail at the case of one child, Katy, and
her parents. We saw how the direction of decision-making
changed several times, with disagreements being managed
within the family, rather than within the assent process offered
by the clinical team. These decisions unfolded by degrees over
a long series of events (Rapley 2008), with the child’s eventual
authority embedded in her ongoing experience of illness
(Alderson et al. 2006a). The decisions were not easily located in
one individual, rather they were distributed over several
individuals (Ashcroft et al. 2003; Edwards & Edwards 2012)
and turned on many issues that were neither clinical nor
ethics-related, such as the child’s wish to get her parents ‘to be
quiet’, and to cut down on treatments that she disliked
(Corrigan 2003). What we saw that this family’s practices were
much more persuasive, and some might argue, coercive, than
those found in studies of children’s and parents’ general views
about medical research or in hypothetical trials (Rossi et al.
2003; Swartling et al. 2011), where parents were reported to
support children in making decisions, without substantially
influencing them or dismissing dissent.
Our findings suggest that even the oldest children rely
heavily on their parents to translate and make sense of
information. Parents played such a substantial role in
understanding what a trial is, as well as the reasons for and
against joining, that it is hard to see how a child could dissent
completely independently from their parents. They subtly
shaped their child’s engagement with the trial and added more
overt persuasion or pressure at many points to the extent that
parents could be seen as ‘producing’ assent. This is in contrast
to the some of the biomedical literature, which sees children’s
decisions as separable from their parents and treats assent as if
it can be achieved relatively independently of the family
context (Tait et al. 2003; Hein et al. 2014). It has been argued
that such approaches misunderstand assent (Sibley et al. 2012),
and that assent should be treated simply as a process to involve
children in the decision-making, in whatever way is appropri-
ate for an individual child (Nuffield Council on Bioethics
2015). The latter approach to assent emphasizes the needs and
preferences of each particular child in the context of their
family, and how s/he can be supported and engaged in the
decision-making process. The findings we report are largely
consistent with this notion of assent, but also point to the
considerable role of the parents in decision-making (Miller
et al. 2004; Joffe et al. 2006).
Limitations
This study has several limitations. First, it included three trials
for chronic conditions, where the process of being informed
about the trials, invited and seeking assent tends to happen
over a long period. Therefore, elements of our findings may
not be transferable to clinical trials conducted in more time
constrained contexts. Second, parents in our study were highly
engaged with informing their children and discussing the trial
with them. It is possible that parents who took part in this
study are committed to mediating for their child in these ways,
and our findings may not be transferable to other families.
Third, in all except two cases, parents were present for at least
part of the child’s interview. Children could readily turn to
parents for help and parents could readily interject, potentially
leading to an amplified picture of parents’ role. Nevertheless,
this context mirrors how discussions about clinical trials take
place in practice. Finally, there are several outstanding
questions about assent requiring specialist ethical analysis that
are beyond the scope of this empirical paper. The Nuffield
Council has recently produced such an ethical analysis
(Nuffield Council on Bioethics 2015).
Practice recommendations and suggestions for further
research
This paper demonstrates the substantial role of parents in the
assent process. Based on this, we suggest that practitioners and
information resources need to a focus on supporting parents to
support their children’s engagement in trial decision-making.
Such support for parents would be consistent with what we
observed of their role. It would also reflect how children valued
and relied upon the input of their parents, and in these
particular trials, how much decisional work was done within
the family and outside the clinic. That is not to say that
practitioners and resources should only engage with children
via their parents – clearly the principles of involving children
and promoting their trust requires practitioners to engage with
children directly. The case of parent–child disagreement that
we saw, where the parents persuaded their reluctant daughter
to enter a trial (only for her to subsequently withdraw), also
reminds us that parental support alone is not sufficient. We
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therefore suggest that alongside supporting parents to support
their children, practitioners should look out for diverging
views between children and parents, and offer children the
chance to discuss the trial separately from their parents.
Further research should identify and evaluate the role of
practitioners in delivering this more personalized and family
orientated approach to consent, and particularly, to under-
stand how practitioners can support parents to support their
child’s engagement outside the clinic or hospital, whilst also
enabling children’s views to be heard.
Key messages
• Most of the relatively small body of research on children’s
accounts of assent to clinical trials does not take account
of the family and social context or involve participants
with real experience of trials. This study aimed to address
these limitations and inform practice in children’s assent.
• We found parents had a considerable mediating role in
how children understood trials and had a large influence
on their views. This role was one that children largely
seemed to welcome.
• Decision-making was embedded in family dynamics and
relationships and happened over time as events unfolded
in the management of the child’s illness.
• In recognition of how decision-making is embedded
within the family and children’s reliance on parents,
practitioners should consider how to support parents to
support their children in understanding and deliberating
about clinical trials.
• This should be accompanied by efforts to identify
divergences of opinion between the two parties and to
enable children’s perspectives to be heard, perhaps by
offering children the opportunity to discuss clinical trials
separately from their parents.
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